Evaluation of Effectiveness and Safety of Transcatheter Mitral Valve Repair Under Moderate Conscious Sedation.

Background. Transcatheter mitral valve repair (TMVR) using the MitraClip system (Abbott Vascular) has become a world-wide, well-established therapeutic alternative to symptomatic patients with severe mitral regurgitation (MR) and prohibitive surgical risk. Currently, TMVRs are performed under general anesthesia. Herein, we aimed to present the effectiveness and safety of TMVR under moderate conscious sedation [MCS). Methods. A total of 102 patients with severe MR [49 primary MRs and 53 secondary MRs) who underwent TMVR with MCS between December 2018 and December 2019 were included. We prospectively evaluated clinical and procedural outcomes using medical records of these patients. Results. Among all the patients, the mean age was 81.6 +/- 3.5 years, 60 [59%] were women, and 72.7% had coronary artery disease. The mean left ventricular ejection fraction was 47.9 +/- 117%, while the MR grade was 3+ in 18.2% of the patients and 4+ in 81.8%. A mean of 1.2 +/- 0.4 clips (range, 1-2 clips) were implanted per patient. Postprocedural MR grade was 1+ or lower in 64 patients (63.6%) and 2+ in 38 patients (36.4%). Procedural duration, clip implant time, and fluoroscopy times were 60 +/- 10.5 minutes, 19.5 +/- 8.0 minutes, and 10.1 +/- 2.1 minutes, respectively. The median required dosage of propofol was 140 mg (interquartile range, 84156 mg). No complications arose from MCS. There was no need for conversion to general anesthesia in any of these patients during the procedure. Conclusions. TMVR can be performed safely and effectively under moderate conscious sedation. Applying moderate conscious sedation may simplify the TMVR procedure and reduce procedural time and costs, while increasing overall patient satisfaction.